The companies used “NewCo” as a placeholder when announcing the new company last year and said a renaming and rebranding would come when the deal closes sometime in 2023.
Since then, Medtronic has filed trademark applications with the U.S. Patent and Trademark Office for Mozarc and Mozarc Medical relating to dialysis products.
Medtronic listed itself as the applicant on five applications filed in August and December. Four more recent applications, filed in January, list Mozarc Medical US LLC as the applicant. All list the same attorney of record and the address of Medtronic’s Fridley, Minnesota headquarters.
Meanwhile, law firm DLA Piper — which represents Medtronic — filed last year to incorporate Mozarc Medical Ireland in Dublin, where Medtronic is officially headquartered.
The U.S. trademark filings describe the Mozarc logo as “the word ‘Mozarc’ with the ‘o’ split into top and bottom; the entire word [is] blue except for the bottom half of the ‘o’, which is green.”
It’s not clear when Mozarc Medical will launch, but Medtronic’s recent voluntary early retirement package (VERP) offer specifically excluded employees who “are conveying with Mozarc Medical.” Eligible employees had until last week to accept that deal, which required retirement on or before April 28.
A job posting for a benefits director who would “ensure global benefits offering for Mozarc are ready for Day 1” said the position would end March 31.
Searching U.S. Securities and Exchange Commission filings for the word Mozarc turns up only one document, a September 2022 employment contract for Avita Medical CEO James Corbett that identifies him as a “board member of privately-held Mozarc.”
Corbett declined to comment when reached by MassDevice.
A Medtronic spokesperson did not offer any information about Mozarc when asked about it by MassDevice last week.
The Mozarc trademark applications cover a long list of goods and services:
Pharmaceutical solutions used in dialysis; fluids for peritoneal or parenteral administration including dextrose in water, dextrose and sodium chloride in water, dextrose and vitamins, dextrose and any combination of sodium chloride, magnesium chloride, calcium chloride, and sodium lactate; dialysis solutions containing vitamins, water, protein, osmotic agents; sterile, non-pyrogenic fluids for use in solutions to be administered parenterally; sugars in water; fluids for use in dialysis containing any amount of icodextrin or polyglucose; medical preparations for use in dialysis containing pharmaceuticals
Computer, processors, and mobile device software, algorithms, and methods used to manage, control, operate and display information from medical devices for the treatment of organ deficiencies, medical devices for renal and extra-renal therapies, medical devices for filtration of bodily fluids and plasma exchanges, dialysis machines, and blood filtering devices; machine learning both supervised and unsupervised for managing kidney prescriptions and monitoring same; cloud infrastructure and related management software to manage patient prescriptions and ordering of consumables, kits, service, and maintenance of equipment
Dialysis machines; medical instruments and apparatus for purification and filtration of blood; medical apparatus and instruments for the treatment of kidney failure; dialysis equipment and parts therefor, including dialysis machines, consoles, sorbent rechargers, dialyzers, filters, and sorbent cartridges; kidney dialysis equipment for peritoneal dialysis, hemodialysis, hemodiafiltration, ultrafiltration, and accessories therefor for use in a home or clinical setting, namely, dialysis machines and disposables for use in dialysis machines, cassettes, tubing sets, tubing and empty containers; computerized electrolyte analyzers; blood cell separating machines, components, and fiber; tubing systems, blood lines, needles, valves, lock caps, valves, catheters, catheter adapters, clamps, cones for dialysis machines; containers for solutions used for the treatment of kidney disease, namely, bags, pouches, cartridges, rigid and semirigid containers for concentrates and solutions in solid or liquid form for medical use; dialyzers; blood filtration; plasma filtrations components and fibers for making same; medical devices and apparatus used to filter fluids and wastes from a patient’s blood; filters for blood and blood components for medical purposes; medical instruments for use in dialysis; catheters and parts and fittings therefor; and tubing for use with catheters; dialyzers; electronic identification apparatus and instruments for dialysis equipment, namely, Radio Frequency Identification and Distribution (RFID) apparatus and instruments, namely, transceivers, transmitters, receivers, readers, antennas and reader management equipment, RFID transponders, RFID tags and RFID evaluation kits comprised of RFID readers and antennas for dialysis equipment, consumables, and kits.
Boston-area job postings that are no longer live but cached online say:
At Mozarc Medical, our vision is to reimagine the future of holistic kidney health technology. Established in 2023 out of equal investments from DaVita, a leading provider of kidney care services, and Medtronic, one of the world’s largest medical device companies, Mozarc Medical offers an exciting and unique start-up experience backed by the support of two long-time industry and market leaders.
Driven by our mission and values, we put our patients at the center of all we do. Our employees play a key role in developing technology solutions that enrich patients’ lives and create meaningful progress in the treatment of kidney disease. Find your purpose and passion at Mozarc Medical.
